Introduction
Establishment of the circulatory system is critical for embryonic development and growth. This entails the fine vascular network comprised of arteries, capillaries and veins that is essential for the tissue perfusion, as well as the architectural pattern of larger vessels that direct blood flow to the various organs and different regions of the body. The embryonic heart and vessels are necessary for a fully functioning fetal circulation and for adaptation to the circulatory changes caused by the cessation of placental blood flow and the beginning of respiration at birth.
The major arterial branches of the thoracic cavity, including the aortic arch, brachiocephalic artery, carotid arteries and subclavian arteries, are formed by the remodeling of symmetrical pairs of embryonic pharyngeal arch arteries (PAAs), also referred to as aortic arch arteries, that arise from the aortic sac and terminate in the right and left dorsal aortae (Hiruma et al., 2002) . Impairment of the development and/or remodeling of the paired PAAs causes various congenital diseases such as right-sided aortic arch (RAA), interruption of the aortic arch (IAA) and aberrant origin of the right subclavian artery (RSA) (A-RSA) in human patients (Barry, 1951) . These morphological defects in major arteries are observed as isolated diseases, as a part of complicated cardiovascular anomalies or as a manifestation of multi-organ syndromes such as 22q11.2 deletion syndrome (Wurdak et al., 2006) . In animal models, numerous signaling molecules have been shown to be involved in the regulation of PAA formation and remodeling, including Tbx1, the transforming growth factor β superfamily, endothelins and the Notch receptors (High et al., 2007; Manderfield et al., 2012; Molin et al., 2004; Yanagisawa et al., 1998) . However, detailed mechanisms by which the aortic arch and its major Mechanisms of Development 139 (2016) [65] [66] [67] [68] [69] [70] [71] [72] [73] branch arteries develop during embryonic stages remain to be elucidated.
Notch signaling plays essential roles in regulating embryonic cardiovascular development in humans as well as in experimental model species (Benedito et al., 2008; Duarte et al., 2004; Herbert and Stainier, 2011; Krebs et al., 2000; Potente et al., 2011) . We and others previously identified a basic helix-loop-helix protein family of Hairy-related transcription factors, independently named Hrt, Hey, Hesr, Chf, Herp or Gridlock, as downstream mediators of Notch signaling in the developing vasculature (Chin et al., 2000; Iso et al., 2001; Kokubo et al., 1999; Leimeister et al., 1999; Nakagawa et al., 1999; Zhong et al., 2000) . Endothelial Hrt/Hey expression is also controlled by bone morphogenetic protein 9 (BMP9)/BMP10-dependent ALK1 receptor signaling, which is indispensable for embryonic vascular development (Larrivée et al., 2012; Somekawa et al., 2012) . Among the three gene family members (Hrt1/Hey1, Hrt2/Hey2 and Hrt3/Heyl), mice null for Hrt2/Hey2 show perinatal lethality due to tricuspid atresia, ventricular septal defect and mitral valve insufficiency (Donovan et al., 2002; Fischer et al., 2004; Kokubo et al., 2005; Xin et al., 2007) . Mouse embryos null for both Hrt1/Hey1 and Hrt3/Heyl show ventricular septal defect and cardiac valve malformations (Fischer et al., 2007) . Combined loss of Hrt1/ Hey1 and Hrt2/Hey2 results in embryonic lethality due to vascular demise similar to that observed in Notch or ALK1 signaling deficient embryos (Fischer et al., 2004; Kokubo et al., 2005; Oh et al., 2000; Urness et al., 2000) .
While the abnormalities of cardiovascular development in these double null mice clearly show the physiological significance of Hrt1/ Hey1, no cardiovascular phenotypes have been reported as yet for Hrt1/Hey1 null mice. In this study, we demonstrate that Hrt1/Hey1 null mice display various anomalies of the aortic arch and its major branch arteries, including RAA, IAA-B and A-RSA. These defects are caused by impaired development of the fourth PAA (PAA4), which is characterized by the reduced expression of Jag1, an endothelial Notch ligand, the abnormality of endothelial tube structure and the lack of vascular smooth muscle cell (VSMC) differentiation. The present study indicates that Hrt1/Hey1 is involved in the regulation of PAA morphogenesis during mouse embryonic development, and further suggests a possible role of the Hrt/Hey transcription factor family in the etiologies of human congenital vascular anomalies.
Results

Perinatal lethality of Hrt1/Hey1 null mice on the C57BL/6N genetic background
We previously generated a mouse line with the replacement of the exons 2-4 of the Hrt1/Hey1 gene with a PGK-neo cassette (Hrt1/ ; TekCre + ) caused embryonic lethality due to severe vascular abnormalities (Morioka et al., 2014) . In parallel with this study performed on a mixed genetic background, Hrt1/Hey1 null mice were bred with C57BL/6N mice up to the tenth generation to examine the phenotypes on a defined genetic background.
On the C57BL/6N background, the genotype distribution from the intercrosses of Hrt1/Hey1 heterozygous mice followed the Mendelian ratio at birth (Table 1) , consistent with previous reports (Fischer et al., 2004; Kokubo et al., 2005) . In contrast, the genotype ratios at 14 and 30 days after birth indicated a significant deviation from the expected inheritance, with about half of Hrt1/Hey1 null mice dying within 2 weeks after birth (Table 1) . The body size of newborns was not significantly different among genotypes, although some Hrt1/Hey1 null neonates exhibited cyanosis and attenuated response to physical stimuli. The remaining Hrt1/Hey1 null pups that came through the postnatal period survived to adulthood, and their susceptibility to various disease stresses is currently under investigation.
2.2. Abnormal morphology of the aortic arch and its branches in Hrt1/Hey1 null newborn mice Because Hrt1/Hey1;Hrt3/Heyl double null mice show suppression of endothelial-mesenchymal transformation in the atrioventricular canal of the developing heart with subsequent ventricular septal defect and cardiac valve malformations (Fischer et al., 2007) , we initially examined whether Hrt1/Hey1 deficiency is associated with defects of cardiac morphogenesis on the C57BL/6N background. Out of twelve Hrt1/Hey1 null newborns examined, however, only two had ventricular septal defect, and none had detectable deformities of the atrioventricular valves. Morphological abnormalities of the cardiac outflow tract, which were often caused by the deficits of cardiac neural crest cell (NCC)-derived cells, were not observed (data not shown), indicating that cardiac dysmorphogenesis was not a major cause of their death.
We then analyzed the structure of major arteries in the thoracic cavity of Hrt1/Hey1 null pups. As shown in Fig. 1 , panels a-d, Hrt1/ Hey1 null mice displayed various types of vessel malformations, which were clearly visualized by India ink injection. To assess the detailed morphology of major arteries and their arrangement with the digestive and respiratory systems, we dissected the arteries, lung, trachea and esophagus out of the body (Fig. 1, e-l) . All wild-type mice had normal vessel morphology (Fig. 1, a, e, i) , where the aortic arch resided on the left side and gave rise to the brachiocephalic artery, which further branched off to form the RSA and right common carotid artery (RCCA), left common carotid artery (LCCA) and left subclavian artery (LSA).
In sharp contrast, Hrt1/Hey1 null mice showed three different types of arterial malformations, namely RAA (Fig. 1, b , f, j), IAA (Fig. 1, c, g, k) and A-RSA (Fig. 1, d , h, l). In Hrt1/Hey1 null mice showing RAA, the RSA and LSA branched off from the descending aorta, and the LSA passed behind the esophagus toward the left upper extremity (Fig. 1, f, j) . In the cases of IAA, the interruption of the aortic arch was observed in the portion between the LCCA and LSA (asterisks in Fig. 1 , panels c and g), and the LSA originated from the proximal end of the descending aorta. This morphological feature of IAA observed in Hrt1/Hey1 null mice closely resembles type B IAA (IAA-B) in human patients (Rauch et al., 1998) . In Hrt1/Hey1 null mice, IAA-B was often complicated with A-RSA (Fig. 1,  g, k) , as observed in human patients. There were mutant mice that showed both IAA-B and RAA (Fig. 1, g, k) , where the aortic arch was present on the right side and connected to the descending aorta in the retroesophageal space. Such complex arrangement of the aortic arch and its branches was distinguished from isolated IAA-B only by the preparation of vessel specimens. In the cases of isolated A-RSA, the RSA arose from the descending aorta, not the brachiocephalic artery, while the aortic arch and other vessels were correctly formed (Fig. 1,  d , h, l).
As shown in Table 2 , these diverse anomalies of the thoracic arterial system collectively occurred in 79% of Hrt1/Hey1 null newborns on the C57BL/6N background (22 out of 28 null mice examined). There are 9 cases of RAA and 6 cases of A-RSA, whereas 7 cases showed IAA-B, IAA-B plus RAA or atypical IAA-B-like anomalies. While we have not thoroughly examined the relationship between the types of vessel anomalies and the lethality, the null mice with IAA-B and related anomalies appeared to die perinatally. Similar major vessel anomalies were also observed with C57BL/6N × C57BL/6J or C57BL/6N × 129X1/SvJ genetic background (Table 2 ).
Defects of PAA formation in Hrt1/Hey1 null mouse embryos
It is of note that, while RAA, IAA-B and A-RSA are morphologically distinct, all of them are caused by the loss of the vascular structures derived from left or right PAA4 (Barry, 1951) . Normally, left PAA4 forms a part of the aortic arch, and RAA can occur as a result of the persistence of right PAA4, compensating for the abnormal involution of left PAA4. Likewise, IAA-B is typically due to developmental defects of left PAA4, while A-RSA is due to those of right PAA4. Accordingly, we next sought to determine if there were developmental abnormalities of PAAs in Hrt1/Hey1 null mouse embryos.
India ink injection into the embryonic heart at embryonic day (E) 10.5 visualized the dorsal aorta and the normal third, fourth and sixth PAAs in wild-type embryos ( Fig. 2A, a) , whereas in Hrt1/Hey1 null embryos PAA4 was hypoplastic or bifurcated ( Fig. 2A, b , c). Coronal sections of the embryos clearly showed that the cavity of PAA4 was very narrow or obliterated in Hrt1/Hey1 null embryos (Fig. 2B, b, b', c, c') . Defects of the PAA4 structure were observed either on the right or left side, and were also present on both sides in one null embryo. Overall penetrance of the PAA4 abnormalities was not complete, and some of Hrt1/Hey1 null embryos did not show discernable deficits in PAA4 development. Such variability and incomplete penetrance were consistent with those of newborn phenotypes in Hrt1/Hey1 null mice.
Lack of VSMCs in structurally-defective PAA4 of Hrt1/Hey1 null embryos
To clarify the characteristics of vascular defects in PAA4 of Hrt1/Hey1 null embryos, we first examined the expression of the markers for endothelial cells (ECs) and VSMCs using immunohistochemistry. Platelet endothelial cell adhesion molecule-1 (PECAM1) immunostaining marked the EC layers of the dorsal aortae and the third, fourth and sixth PAAs in wild-type embryos at E10.5 and E11.5 (Fig. 3, a', a", d', d") . In Hrt1/ Hey1 null embryos, the EC layers were also marked by PECAM1, but the PAA4 structure delineated by endothelial PECAM1 staining was often severely disorganized or obstructed (Fig. 3, c' , c", f', f"). This abnormality was not completely penetrant, and some of Hrt1/Hey1 null embryos had an apparently normal endothelial tube structure (Fig. 3, b' , b", e', e"), which was consistent with preceding morphological studies ( Table 2 ). It is noteworthy that the expression of PECAM1 was maintained not only in the structurally-intact PAA4 but also in the defective PAA4 (Fig. 3, b" , c", e", f"). In addition, VE-cadherin-positive cells were also detected in the structurally-defective PAA4 of Hrt1/Hey1 null embryos (data not shown), indicating that EC differentiation was not affected by the Hrt1/Hey1 deficiency.
In contrast, the expression of the smooth muscle cell marker SM22α displayed significant differences between wild-type and Hrt1/Hey1 null embryos. In wild-type embryos, SM22α-positive VSMCs started to surround a part of the PECAM1-positive endothelial layer of PAA4 at E10.5 (Fig. 3, a' , a'''), and covered most of vascular walls at E11.5 (Fig. 3, d ', d'''). In sharp contrast, SM22α-positive cells were nearly absent from the structurally-defective PAA4 of Hrt1/Hey1 null embryos at either stage (Fig. 3, c' , c''', f', f'''), while SM22α-positive cells were present at normal levels in the structurallyintact PAA4 of null embryos (Fig. 3, b' , b''', e', e'''). These results suggest that impaired formation of the VSMC layer is a cause of abnormal PAA4 morphogenesis, leading to congenital malformations of the aorta and its branches in Hrt1/Hey1 null mice.
2.5. Unaltered migration, proliferation and apoptosis of NCCs in the fourth pharyngeal arch of Hrt1/Hey1 null embryos Since VSMCs of PAAs are mainly derived from NCCs and the PAA4 phenotype can result from ablation of the cardiac NCCs in avian embryos (Bockman et al., 1987) , we attempted to determine whether the NCC migration from the dorsal neural tube to the pharyngeal arches was disturbed in Hrt1/Hey1 null embryos. Lineage tracing of cardiac NCCs was performed by using Wnt1-Cre mice crossed with R26R LacZ reporter mice (Soriano, 1999) . Descendent of the cardiac NCCs marked with β Fig. 3 . Structural defects of the fourth pharyngeal arch artery were associated with the impairment of endothelial tube formation and the loss of vascular smooth muscle cells in Hrt1/Hey1 null embryos. Endothelial cells (ECs, shown in red) and vascular smooth muscle cells (VSMCs, green) are marked with platelet endothelial cell adhesion molecule-1 (PECAM1) and SM22α, respectively, in coronal sections of E10.5 (a-c) and E11.5 (d-f) wild-type (a, d) and Hrt1/Hey1 null embryos (b, c, e, f). For null embryos, the structurally-intact (b, e) and defective (c, f) fourth pharyngeal arch arteries (PAA4) are shown. The images of right PAA4 (surrounded by dotted lines in panels a-f) are presented with higher magnification (a'-f', a"-f", a'''-f'''). In wild-type embryos, the EC tube structure of PAA4 was formed by E10.5. VSMCs started to surround a part of the EC layer at E10.5 (a'''), and covered most of vascular walls at E11.5 (d'''). In the structurally-defective PAA4 of Hrt1/Hey1 null embryos, the EC tube structure was not well-formed, being small and disorganized (c", f"), and SM22α-positive VSMCs were hardly observed (c''', f'''). Even in null embryos, the structurally-intact PAA4 showed normal morphology and marker expression (b', b", b''', e', e", e'''). The nuclei were stained with DAPI (blue). Scale bars represent 200 μm (a-f) or 25 μm (a'-f', a"-f", a'''-f''').
galactosidase expression populated pharyngeal arches normally in Hrt1/Hey1 null embryos (Fig. 4A, a-c) . The number of β galactosidasepositive cells in the fourth pharyngeal arches appeared unchanged between wild-type and Hrt1/Hey1 null embryos as well as between the fourth pharyngeal arches of Hrt1/Hey1 null embryos with and without PAA4 defects. These results were consistent with our observation that NCC-derived structures in the outflow tract were not affected in Hrt1/ Hey1 null embryos.
We also analyzed the proliferation and cell death of cardiac NCCs that migrated into the fourth pharyngeal arches at E10.5. The distribution of the cells positive for phosphorylated histone H3 (pH3) in the fourth pharyngeal arches was equivalent between wild-type and Hrt1/ Hey1 null embryos, regardless of the PAA4 structural defects (Fig. 4B,  a-c) . The ratio of the pH3-positive cell number to the total cell number in the fourth pharyngeal arches was not significantly different between wild-type and Hrt1/Hey1 null embryos (5.61 ± 0.27% vs. 5.68 ± 0.29%, p = 0.77), and in Hrt1/Hey1 null embryos, not different between the fourth pharyngeal arches that contained the structurally-intact and defective PAA4 (5.70 ± 0.33% vs. 5.66 ± 0.23%, p = 0.89). Cleaved caspase-3-positive cells did not increase and were rarely detectable in the fourth pharyngeal arches of Hrt1/Hey1 null embryos (Fig. 4B, d-f) . Taken together, the migration, proliferation and apoptotic cell death of cardiac NCCs were not significantly altered in the fourth pharyngeal arches of Hrt1/Hey1 null embryos.
2.6. Down-regulation of Jag1 expression in structurally-defective PAA4 of Hrt1/Hey1 null embryos
We then determined whether the expression of signaling molecules implicated in PAA development was affected in Hrt1/Hey1 null embryos. While the mice carrying a mutation in the Tbx1, Fgf8 or Gbx2 gene are known to show abnormal development of PAA4, including impaired VSMC recruitment, the expression of these genes was not altered in the pharyngeal arches of Hrt1/Hey1 null embryos (Fig. 5A, a-f) .
Expression of the Notch ligand Jag1 in ECs is also essential for the establishment of VSMC coverage of developing PAA vessel walls (High et al., 2008) . Therefore, we analyzed Jag1 mRNA expression using in situ hybridization of wild-type and Hrt1/Hey1 null embryos. At E10.5, the PAA wall is mainly composed of ECs, and Jag1 mRNA was detected in arterial ECs, pharyngeal ectoderm and pharyngeal pouch in wildtype embryos (Fig. 5B, a) . In the structurally-defective PAA4 of null embryos, however, the endothelial expression of Jag1 mRNA was severely reduced, while its expression was unchanged in pharyngeal ectoderm and pouch (Fig. 5B, b) . At E11.5, Jag1 protein expression was observed in the EC and VSMC layers in wild-type embryos (Fig. 5C, a) . In Hrt1/ Hey1 null embryos, the structurally-defective PAA4 was not covered with VSMCs. Jag1 protein expression markedly decreased in PECAM1-positive ECs, and was not detectable in surrounding NCC-derived mesenchymal cells (Fig. 5C, c') .
Importantly, the expression of Jag1 mRNA and protein in ECs was maintained in the structurally-intact PAA4 of Hrt1/Hey1 null embryos at the equivalent levels to those in wild-type embryos (Fig. 5C, b) , indicating that the suppression of Jag1 expression was not inevitable in PAA4 lacking Hrt1/Hey1. However, the decreased Jag1 expression was associated with morphological defects of PAA4 and might lead to alteration of downstream cellular signaling that affects VSMC differentiation and assembly. It has been demonstrated that the expression of Jag1, Notch3 and the Hrt/Hey family proteins in the VSMC layer of the vessel wall depends on that of Jag1 in ECs (Liu et al., 2009 ). As mentioned above (Fig. 5C, c') , the Jag1 protein expression was not observed in the cells surrounding the defective EC structure of PAA4 in Hrt1/Hey1 null embryos. In addition, the expression of Notch3 and Hrt2/Hey2 significantly decreased around the structurally-defective PAA4 of Hrt1/Hey1 null embryos (Fig. 5D, b, d ). These results suggest the possibility that, while the initial pathological event due to the Hrt1/Hey1 mutation is still unknown, the disorganization of EC tube structure associated with decreased Jag1 expression might cause the impairment of VSMC differentiation and assembly in PAA4. The specific defects in PAA4 morphogenesis lead to characteristic anomalies of the aortic arch and its branches, RAA, IAA-B and A-RSA, in Hrt1/Hey1 null mice.
Discussion
Impairment of PAA4 formation and lethal malformations of the aortic arch and its branches in Hrt1/Hey1 null mice
The present study demonstrates that the deletion of the gene encoding Hrt1/Hey1, a member of Hairy-related transcription factors, causes anomalies of the aortic arch and its major branch arteries, RAA, IAA-B and A-RSA, in mice. These vascular defects are caused by the impairment of PAA4 development, which is characterized by abnormalities of endothelial tube formation and VSMC differentiation.
It was previously reported that Hrt1/Hey1 null mice did not show overt phenotypes and survived to adulthood on the C57BL/6 or C57BL/ 6 × 129 background (Fischer et al., 2004; Kokubo et al., 2005) . Apparent discrepancy of null phenotypes is likely due to the difference of genetic Fig. 4 . Cardiac neural crest cell migration, proliferation and apoptosis were intact in Hrt1/ Hey1 null embryos. (A) Lineage tracing of neural crest cell-derived progenitors was performed using the Wnt1-Cre; R26R LacZ reporter system in wild-type and Hrt1/Hey1 null embryos at E10.5. β galactosidase (β-gal) immunostaining of coronal sections revealed that cardiac neural crest cell-derived cells populated the fourth pharyngeal arches in wild-type (a) and null embryos (b, c) at equivalent levels. (B) Cell proliferation and apoptosis were analyzed using the immunostaining of phosphorylated histone H3 (pH3) and cleaved caspase-3 (CC3), respectively, in the fourth pharyngeal arches of wild-type (a, d) and Hrt1/Hey1 null embryos (b, c, e, f) at E10.5. The pH3 expression was not significantly altered in the fourth pharyngeal arches of null embryos, regardless of the presence or absence of structural defects of pharyngeal arch arteries (b, c). Few apoptotic cells marked with the CC3 expression were present in the fourth pharyngeal arches of wildtype embryos (d), and they did not increase in Hrt1/Hey1 null embryos (e, f). In (A) and (B), the nuclei were stained with DAPI. Arrowheads indicate the fourth pharyngeal arches. Scale bars represent 100 μm.
background. We consistently observed the same vascular abnormalities on the C57BL/6N, C57BL/6N × C57BL/6J or C57BL/6N × 129X1/SvJ genetic background (Table 2) , while vascular morphogenesis appeared to be unaffected on the C57BL/6J background (M. F. Utset, unpublished observation). Penetrance of similar PAA4 phenotypes in mutant mouse models is influenced by the genetic background (Byrd and Meyers, 2005; Calmont et al., 2009; Simrick et al., 2012; Taddei et al., 2001; Villar et al., 2005; Vitelli et al., 2002) . For example, Tbx1 heterozygous mice show highly variable penetrance of PAA4 defects depending on their genetic background (Calmont et al., 2009; Simrick et al., 2012; Vitelli et al., 2002) . Likewise, the phenotypes caused by the deletion of Hrt/Hey family genes are altered by the genetic background (Fischer et al., 2007; Sakata et al., 2002; Sakata et al., 2006) , as seen with cardiac malformations and perinatal lethality in Hrt2/Hey2 null mice. Studies on possible modifier genes regarding these cardiovascular phenotypes may help identify factors related to the susceptibility to congenital heart diseases in humans.
Specificity and variability of vascular defects in Hrt1/Hey1 null mice
The developmental defects due to the Hrt1/Hey1 deficiency specifically affect PAA4, even though Hrt1/Hey1 is expressed at equivalent levels in the third, fourth and sixth PAAs (High et al., 2007) and the expression of Hrt2/Hey2 and Hrt3/Heyl does not show compensatory upregulation in any of these PAAs in Hrt1/Hey1 null embryos (data not shown). Morphogenetic abnormalities are observed more frequently in PAA4 than in other PAAs in mouse models that show impairment of PAA development (Calmont et al., 2009; Frank et al., 2002; Gitler et al., 2004; Randall et al., 2009 ). PAA4 has unique characteristics including the presence of a non-muscular region where the expression of smooth muscle α-actin is reduced or absent (Bergwerff et al., 1999; Molin et al., 2004) , and which may explain why PAA4 is more susceptible to the lack of Hrt1/Hey1 or other genes.
Meanwhile, the structural abnormalities of PAA4 occurred either on the right or left side in Hrt1/Hey1 null embryos, and were also present Fig. 5 . Endothelial Jag1 expression and downstream Notch signaling were impaired in the structurally-defective fourth pharyngeal arch arteries of Hrt1/Hey1 null embryos. (A) Whole mount in situ hybridization using E9.5 embryos revealed that mRNA expression of Tbx1 (a, b), Fgf8 (c, d) and Gbx2 (e, f) was unchanged in Hrt1/Hey1 null embryos. Yellow brackets indicate the presumptive regions that develop into the fourth and sixth pharyngeal arches. (B) Section in situ hybridization indicated that, in Hrt1/Hey1 null embryos, Jag1 mRNA expression was markedly reduced in the endothelial layer of the structurally-defective fourth pharyngeal arch artery (PAA4) at E10.5, while it was unaltered in the pharyngeal ectoderm and pharyngeal pouch. Arrowheads indicate the fourth pharyngeal arch arteries. (C) Immunostaining of Jag1 and platelet endothelial cell adhesion molecule-1 (PECAM1) was performed using coronal sections of E11.5 embryos. Arrowheads indicate PAA4, and the magnification is shown in the insets. Jag1 protein expression was severely reduced (c'), while PECAM1 expression was maintained (c") in the structurally-defective PAA4 of Hrt1/Hey1 null embryos. In contrast, Jag1 expression was unchanged in the structurally-intact PAA4 of null embryos (b'). on both sides in one null embryo. A diversity of vascular anomalies in Hrt1/Hey1 null newborn mice, RAA, IAA-B and A-RSA, was consistent with variable laterality of embryonic PAA4 defects. Such variability has been reported for mouse embryos harboring mutations of other genes (Byrd and Meyers, 2005; Papangeli and Scambler, 2013) . Mature structure of the aortic arch and its major branches is built through not only the persistence but also the regression of PAAs. It is likely that the lack of Hrt1/Hey1 leads to the imbalance of cellular signaling that coordinates the persistence and regression of embryonic arteries, making PAA4 prone to be structurally affected by additional stresses.
3.3. Down-regulation of endothelial Jag1 expression in PAA4 of Hrt1/Hey1 null embryos
The expression of endothelial differentiation markers, PECAM1 and VE-cadherin, was not altered in the structurally-defective PAA4 of Hrt1/Hey1 null embryos; however, the endothelial expression of Jag1 mRNA and protein was significantly down-regulated. It has been shown that EC-specific deletion of murine Jag1 results in the reduction of VSMC differentiation in the dorsal aorta and PAAs (High et al., 2008) . During embryonic vascular formation, endothelial Jag1 stimulates VSMC differentiation from adjacent mesenchymal cells by inducing the expression of several genes including Jag1, itself, transgelin/ SM22α, Notch3 and the Hrt/Hey family genes (Liu et al., 2009; Zhao et al., 2012) . Such induction of gene expression through Notch signaling between ECs and VSMCs appeared lost in the structurally-defective PAA4 of Hrt1/Hey1 null embryos. These results suggest that the decreased Jag1 expression in ECs may be a major reason why VSMC differentiation and assembly are severely impaired in PAA4 of Hrt1/Hey1 null embryos, leading to the anomalies of the aortic arch and its major branches.
However, down-regulation of Jag1 expression was not observed in the structurally-intact PAA4 of Hrt1/Hey1 null embryos, clearly indicating that Jag1 expression can be maintained in PAA4 despite the lack of Hrt1/Hey1 protein, and therefore Jag1 is probably not a direct target of Hrt1/Hey1-dependent transcriptional regulation. Moreover, Hrt/Hey proteins mainly suppress the transcription of target genes by recruiting transcriptional repressors such as histone deacetylases (Stefanovic et al., 2014) , and their loss is supposed to result in the up-regulation of target genes. It is still unclear how the lack of Hrt1/Hey1 alters Jag1 expression in the structurally-defective PAA4 of Hrt1/Hey1 null embryos, but among known regulators of Jag1 expression (Estrach et al., 2006; Larrivée et al., 2012; Masumura et al., 2009; Morikawa et al., 2011) , shear stress might be a link between the structural abnormalities of PAA4 and down-regulation of endothelial Jag1 expression in PAA4 of Hrt1/Hey1 null embryos. It has been shown that Jag1 expression is upregulated by mechanical stress due to shear flow on ECs (Masumura et al., 2009) . Mechanical signals caused by the proper range of blood flow into developing PAAs are necessary for the formation and maintenance of the PAA structure (Yashiro et al., 2007) . It is reasonable to hypothesize that, once the endothelial tube formation is impaired at the earlier stage of PAA4 morphogenesis in Hrt1/Hey1 null embryos, the structural deficits of PAA4 cause a reduction of blood flow, the suppression of endothelial Jag1 expression, and then the loss of VSMC differentiation and assembly. Such a cascade of events should further compound the PAA4 structural defects and eventually lead to its interruption.
Implication of Hrt1/Hey1 in Notch signaling during PAA development
It is well known that the expression of the Hrt/Hey family genes is transcriptionally activated by Notch signaling in developing vasculature and other tissues (Maier and Gessler, 2000; Nakagawa et al., 2000) . Notch signaling is clearly involved in the formation of the aortic arch and its major branches (High et al., 2009; High et al., 2007; Manderfield et al., 2012; Mead and Yutzey, 2012) , and it is important to investigate if Hrt1/Hey1 regulates PAA4 development downstream of Notch signaling. There are critical points of difference, however, between the characteristics of Hrt1/Hey1 null mice and those of mouse models for the Notch signaling deficiency.
Importance of Notch signaling in PAA development has been shown by the phenotype analyses of the mice with the expression of the dominant-negative form of the MAML co-activator or the deletion of Jag1 (High et al., 2009; High et al., 2007; Manderfield et al., 2012) . While vascular anomalies similar to those observed in Hrt1/Hey1 null mice, such as RAA, IAA-B and A-RSA, are most frequently observed in the mice where Notch signaling is specifically inhibited in the second heart field (High et al., 2009) , the expression of Hrt1/Hey1 in the second heart field has not been proven yet. Those mice with Notch signal inhibition in the second heart field display various cardiac anomalies, including persistent truncus arteriosus and double outlet right ventricle, which are caused by abnormal NCC migration (High et al., 2009) . By contrast, cardiac malformations only rarely occurred in Hrt1/Hey1 null mice, and the NCC migration appeared intact. Morphological abnormalities of the aortic arch and its major branches are also present when Notch signaling is abrogated in NCC-derived cells (High et al., 2007) . In those mice, however, dysmorphogenesis of the sixth PAA-derived vessels is more common than that of PAA4-derived vessels and the initial defects of endothelial tube structure appear insignificant, which differs from the observation in Hrt1/Hey1 null embryos. These results suggest that Hrt1/Hey1 does not simply act as a Notch downstream effector for PAA development and the formation of the aortic arch and its branches, and further studies are necessary to elucidate signaling pathways that function upstream of Hrt1/Hey1 in PAA development independently or in cooperation with Notch signaling.
Mechanisms of actions and downstream genes of Hrt1/Hey1 in PAA development
It is of interest that the deletion of Hes1, another Notch signal target gene encoding a potential hetero-dimerization partner of Hrt/Hey proteins, results in the PAA4 defects highly similar to those in Hrt1/Hey1 null embryos (van Bueren et al., 2010) . Deletion of other Hrt/Hey and Hes superfamily genes does not cause impairment of PAA development in mice. Hetero-dimers of Hrt/Hey proteins and Hes1 elicit potent activity of transcriptional repression in in vitro analyses (Iso et al., 2001 ), but their physiological significance has not been demonstrated in vivo. It is tempting to speculate that Hrt1/Hey1 and Hes1 may function as a dimer, at least in part, in transcriptional regulation during PAA4 development.
While previous studies clearly demonstrated that the lack of Hrt/Hey family genes caused various cardiovascular abnormalities and lethality in mice, it has not been clarified which genes are directly regulated by Hrt/Hey-mediated transcriptional repression and are responsible for such developmental defects (Donovan et al., 2002; Fischer et al., 2004; Fischer et al., 2007; Kokubo et al., 2005; Morioka et al., 2014; Xin et al., 2007) . In the present study, we have not identified the genes that are transcriptionally regulated by Hrt1/Hey1 and play essential roles for PAA4 development. Expression patterns of candidate genes such as Tbx1, Fgf8 and Gbx2 did not change in Hrt1/Hey1 null embryos. Hrt/ Hey controls transcription of target genes not only by binding to the E-box DNA motif but also through complex formation with other DNA-binding transcription factors (Kathiriya et al., 2004; King et al., 2006; Nakagawa et al., 2000) . The latter mode of actions likely increases the number of Hrt/Hey downstream genes, and the summative effects onto numerous genes may cause the phenotypes due to the Hrt/Hey mutations.
Hrt1/Hey1 is expressed outside the vessel wall in mouse embryos, including in the pharyngeal ectoderm and cardiac atrium (Nakagawa et al., 1999) , and it is formally possible that the defects observed in PAA4 development in Hrt1/Hey1 null embryos are caused by altered signals from one or more of those surrounding tissues. As described above, it will be important to examine if Hrt1/Hey1 is expressed in the second heart field downstream of Notch signaling. However, the structural abnormalities of PAA4 were first observed at the stage of endothelial tube formation in Hrt1/Hey1 null embryos, suggesting that the Hrt1/ Hey1-dependent transcriptional regulation in ECs was essential for PAA4 development. It is of note that, in addition to Hrt1/Hey1, Hrt2/ Hey2 is expressed in ECs of developing arteries (Morioka et al., 2014) . They play a complementary role in early vascular formation, and only double knockout mice show vascular defects and embryonic lethality (Fischer et al., 2004; Kokubo et al., 2005; Morioka et al., 2014 ). In contrast, Hrt2/Hey2 apparently failed to compensate for the lack of Hrt1/ Hey1 in PAA4 development, and consistently, Hrt2/Hey2 null mice did not display PAA phenotypes on the C57BL/6N background (data not shown). Studies using the cell-type-specific Hrt1/Hey1 deletion by the Cre-loxP system and the genome-wide analysis of Hrt1/Hey1 downstream genes are required to elucidate the mechanism of specific Hrt1/Hey1 functions in PAA development.
Experimental procedures
Mice
Animal experiments were performed with the approval of the institutional animal care and use committee of Nara Medical University. C57BL/6N and C57BL/6J mice were purchased from CLEA Japan, and 129X1/SvJ mice were obtained from Japan SLC. The Hrt1/Hey1 null mouse line (Morioka et al., 2014) was maintained with C57BL/ 6N genetic background, mixed C57BL/6N × C57BL/6J background or mixed C57BL/6N × 129X1/SvJ background. Wnt1-Cre mouse line (Danielian et al., 1998) was maintained with C57BL/6NCr genetic background. Sequences of genotyping PCR primers are available upon request. In timed mating experiments, noon on the day when a copulation plug was found was defined as E0.5.
Ink injection
Newborn mice and embryos were fixed in 4% paraformaldehyde for 30 min to overnight at 4°C, and India ink was injected into the aorta or the outflow tract of the heart using a fine glass capillary pipette.
Immunohistochemistry
Immunohistochemistry was performed as previously described (Morioka et al., 2014) , using a primary antibody against PECAM1 (BD Biosciences, #550274), transgelin/SM22α (Abcam, ab14106), β galactosidase (Abcam, ab9361), pH3 (Cell Signaling, #9701), cleaved caspase-3 (Cell Signaling, #9661), Jag1 (Santa Cruz, sc-8303), Notch3 (Abcam, ab23426) or Hrt2/Hey2 (ProteinTech, #10597-1-AP).
The number of DAPI-and pH3-positive cells was counted using Cell Counter, a plugin of the ImageJ software, on three embryos (five sections per embryo) each for wild-type and Hrt1/Hey1 null embryos. Student's t test was used for the statistical analysis.
in situ hybridization
For whole mount in situ hybridization, mouse embryos were fixed in 4% paraformaldehyde overnight, dehydrated and rehydrated in the methanol series. Digoxigenin-labeled RNA probes for mouse Tbx1 (NM_011532, nucleotide 504-903), Fgf8 (NM_010205, nucleotide 462-1008) and Gbx2 (NM_010262, nucleotide 966-1589) were prepared by in vitro transcription and used for hybridization. Embryos were then treated with 10% goat serum containing 2 mM levamisole for blocking, and were incubated with anti-digoxigenin antibody (Roche) overnight at 4°C. BM purple (Roche) was used for the color reaction.
To detect Jag1 mRNA expression, frozen sections were hybridized with a digoxigenin-labeled RNA probe (NM_013822, nucleotide 493-2200). The signal was detected by using anti-digoxigenin antibody (Roche) and NBT/BCIP substrates (Wako).
